↓ Skip to main content

Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions

Overview of attention for article published in European Respiratory Journal, September 2003
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
1 patent

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
117 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Melioidosis: an important cause of pneumonia in residents of and travellers returned from endemic regions
Published in
European Respiratory Journal, September 2003
DOI 10.1183/09031936.03.00006203
Pubmed ID
Authors

B.J. Currie

Abstract

Melioidosis is endemic in South East Asia, Asia and northern Australia. Infection usually follows percutaneous inoculation or inhalation of the causative bacterium, Burkholderia pseudomallei, which is present in soil and surface water in the endemic region. While 20-36% of melioidosis cases have no evident predisposing risk factor, the vast majority of fatal cases have an identified risk factor, the most important of which are diabetes, alcoholism and chronic renal disease. Half of all cases present with pneumonia, but there is great clinical diversity, from localised skin ulcers or abscesses without systemic illness to fulminant septic shock with multiple abscesses in the lungs, liver, spleen and kidneys. At least 10% of cases present with a chronic respiratory illness (sick > 2 months) mimicking tuberculosis and often with upper lobe infiltrates and/or cavities on chest radiography. As with tuberculosis, latency with reactivation decades after infection can also occur, although this is rare. Confirmation of diagnosis is by culture of B. pseudomallei from blood, sputum, throat swab or other samples. Microbiology laboratories need to be informed of the possibility of melioidosis, as those not familiar with it can misidentify the organism. Antibiotic therapy is initial intensive therapy with i.v. ceftazidime or meropenem or imipenem +/- cotrimoxazole for > or = 10 days, followed by eradication therapy with cotrimoxazole +/- doxycycline +/- chloramphenicol (first 4 weeks only) for > or = 3 months. Melioidosis has been increasingly recognised in returning travellers in Europe and recently melioidosis and colonisation with B. pseudomallei have been documented in cystic fibrosis patients visiting or resident in endemic areas.

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Malaysia 2 2%
Argentina 1 <1%
Thailand 1 <1%
Australia 1 <1%
Unknown 112 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 20%
Student > Master 22 19%
Other 13 11%
Researcher 12 10%
Student > Postgraduate 8 7%
Other 24 21%
Unknown 15 13%
Readers by discipline Count As %
Medicine and Dentistry 46 39%
Agricultural and Biological Sciences 19 16%
Biochemistry, Genetics and Molecular Biology 10 9%
Immunology and Microbiology 5 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 11 9%
Unknown 22 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2012.
All research outputs
#3,110,131
of 11,274,188 outputs
Outputs from European Respiratory Journal
#2,044
of 5,026 outputs
Outputs of similar age
#34,762
of 105,028 outputs
Outputs of similar age from European Respiratory Journal
#16
of 31 outputs
Altmetric has tracked 11,274,188 research outputs across all sources so far. This one is in the 49th percentile – i.e., 49% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,026 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,028 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.